Evidence map›Paper›PMID 21653884›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Atypical protein kinase C (aPKCzeta and aPKClambda) is dispensable for mammalian hematopoietic stem cell activity and blood formation.

Amitava Sengupta, Angeles Duran, Eri Ishikawa, Maria Carolina Florian, Susan K Dunn, Ashley M Ficker, Michael Leitges, Hartmut Geiger, Maria Diaz-Meco, Jorge Moscat and 1 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Amitava SenguptaDivision of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Angeles Duran
Eri Ishikawa
Maria Carolina Florian
Susan K Dunn
Ashley M Ficker
Michael Leitges
Hartmut Geiger
Maria Diaz-Meco
Jorge Moscat
Jose A Cancelas
Cincinnati Children's Hospital Medical Center · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Cincinnati Medical Center · USUniversität Ulm · DEUniversity of Oslo · NO

Funding

Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
The p62/atypical PKC signaling complex in Th2 differentiation and asthmaR01AI072581 · NIAID · UNIVERSITY OF CINCINNATI · PI MOSCAT, JORGE · 2008 to 2012
$2.1M
Role and mechanism of action of p62/Sqstm1 in Ras-induced tumorigenesis in lungR01CA132847 · NCI · UNIVERSITY OF CINCINNATI · PI MOSCAT, JORGE · 2009 to 2013
$2.0M
The Par-4/PKCz complex in prostate cancerR01CA134530 · NCI · UNIVERSITY OF CINCINNATI · PI DIAZ MECO CONDE, MARIA TERESA · 2009 to 2013
$1.8M
Rac GTPase Inhibition in Chronic Myelogenous LeukemiaR01HL087159 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CANCELAS, JOSE A. · 2009 to 2012
$1.7M
Obesity-Induced Inflammation and Insulin Resistance by the p62/PKCzeta SignalingR01DK088107 · NIDDK · UNIVERSITY OF CINCINNATI · PI MOSCAT, JORGE · 2010 to 2012
$1.1M
Cancer Research UKNCI NIH HHS R01 CA132847NCI NIH HHS R01-CA132847NCI NIH HHS R01 CA134530NCI NIH HHS R01-CA134530NHLBI NIH HHS R01 HL087159NHLBI NIH HHS R01-HL087159NIAID NIH HHS R01 AI072581NIAID NIH HHS R01-AI072581NIDDK NIH HHS P30 DK090971NIDDK NIH HHS R01 DK088107
6 · The paper itself

Abstract

The stem-cell pool is considered to be maintained by a balance between symmetric and asymmetric division of stem cells. The cell polarity model proposes that the facultative use of symmetric and asymmetric cell division is orchestrated by a polarity complex consisting of partitioning-defective proteins Par3 and Par6, and atypical protein kinase C (aPKCζ and aPKCλ), which regulates planar symmetry of dividing stem cells with respect to the signaling microenvironment. However, the role of the polarity complex is unexplored in mammalian adult stem-cell functions. Here we report that, in contrast to accepted paradigms, polarization and activity of adult hematopoietic stem cell (HSC) do not depend on either aPKCζ or aPKCλ or both in vivo. Mice, having constitutive and hematopoietic-specific (Vav1-Cre) deletion of aPKCζ and aPKCλ, respectively, have normal hematopoiesis, including normal HSC self-renewal, engraftment, differentiation, and interaction with the bone marrow microenvironment. Furthermore, inducible complete deletion of aPKCλ (Mx1-Cre) in aPKCζ(-/-) HSC does not affect HSC polarization, self-renewal, engraftment, or lineage repopulation. In addition, aPKCζ- and aPKCλ-deficient HSCs elicited a normal pattern of hematopoietic recovery secondary to myeloablative stress. Taken together, the expression of aPKCζ, aPKCλ, or both are dispensable for primitive and adult HSC fate determination in steady-state and stress hematopoiesis, contrary to the hypothesis of a unique, evolutionary conserved aPKCζ/λ-directed cell polarity signaling mechanism in mammalian HSC fate determination.

Indexed as

HematopoiesisAnimalsCell DifferentiationCell LineageCell PolarityCell ProliferationFemaleFlow CytometryGene ExpressionHematopoietic Stem CellsHematopoietic Stem Cell TransplantationIsoenzymesMaleMiceMice, Inbred StrainsMice, KnockoutIsoenzymesPKC-3 proteinProtein Kinase CProtein Kinase C-lambdaProtein Kinase C zeta

Identifiers

PMID21653884
PMCPMC3116405
OpenAlexW2010038916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.